Sign up and fund a new Wall St account and get a full U.S. share.Sign up and fund a new Wall St account and get a full share randomly chosen between GoPro, Dropbox or Nike.T&Cs apply
Cartesian Therapeutics, Inc. is a clinical-stage company pioneering cell therapy for the treatment of autoimmune diseases. It leverages its proprietary technology and manufacturing platform to introduce one or more mRNA molecules into cells to enhance their function. The Company’s lead asset, Descartes-08, is a chimeric antigen receptor T-cell therapy (CAR-T) entering Phase 3 clinical development for patients with generalized myasthenia gravis and Phase 2 development for systemic lupus erythematosus, with a Phase 2 basket trial planned in additional autoimmune indications. The Company’s clinical-stage pipeline also includes Descartes-15, a next-generation, autologous anti-B-cell maturation antigen (BCMA) CAR-T being evaluated in a Phase 1 trial in patients with multiple myeloma. Descartes-08 is an autologous chimeric antigen receptor T-cell therapy product targeting B-cell maturation antigen in clinical development for generalized myasthenia gravis and systemic lupus erythematosus.
Find out what a historical investment in Cartesian Therapeutics In would be worth today using our RNAC stock calculator.
Buying RNAC shares in Australia can be done through an online investing platform, such as Stake. Follow the simple steps below to start investing in Cartesian Therapeutics In in minutes.
Sign up with some I.D. and zero paperwork
Add funds to your account
Make your first investment in RNAC
What is the ticker symbol of Cartesian Therapeutics In?
The ticker symbol for Cartesian Therapeutics In is RNAC.
How much is one share of RNAC?
One share of RNAC is valued at $5.89 as of 20 November 2026.
What is the market capitalisation of Cartesian Therapeutics In RNAC?
As of 20 November 2026 Cartesian Therapeutics In has a market cap of $192.17M.
What is the 52-week high for Cartesian Therapeutics In stock?
The Cartesian Therapeutics In 52-week high stock price is $11.00.
What is the 52-week low for Cartesian Therapeutics In stock?
The Cartesian Therapeutics In 52-week low stock price is $5.60.
Can I buy RNAC shares through Stake, an investing platform like CommSec, Selfwealth or Superhero?
Yes, the Stake investing platform allows you to buy RNAC shares and over 13,000 more stocks and ETFs across the ASX and Wall St.
This is not financial product advice nor a recommendation to invest in the securities listed. Past performance is not a reliable indicator of future performance. As always, do your own research and consider seeking financial, legal and taxation advice before investing. No representation is made as to the timeliness, reliability, accuracy or completeness of the market data provided.
Invest in RNAC on Stake
Buy RNAC from US$3 brokerage
Invest in 11,000+ U.S. stocks and ETFs
Own a slice of RNAC from only US$10 with fractional shares